REESE C RICHARD 4

4 · CHARLES RIVER LABORATORIES INTERNATIONAL INC · Filed Dec 8, 2017

Form 4

Period: 2017-12-06

Director

Transactions

Exercise/Conversion
Common Stock
2017-12-06$33.93/sh+4,540$154,042→ 55,984 total
Exercise/Conversion
Stock Options (Right to Buy)
2017-12-06−4,540→ 0 total
Exercise: $33.93From: 2013-05-09Exp: 2019-05-09→ Common Stock (4,540 underlying)
Exercise/Conversion
Stock Options (Right to Buy)
2017-12-06−4,030→ 0 total
Exercise: $43.39From: 2014-05-08Exp: 2020-05-08→ Common Stock (4,030 underlying)
Exercise/Conversion
Common Stock
2017-12-06$43.39/sh+4,030$174,862→ 60,014 total
Exercise/Conversion
Stock Options (Right to Buy)
2017-12-06−7,740→ 0 total
Exercise: $40.27From: 2012-05-11Exp: 2018-05-11→ Common Stock (7,740 underlying)
Exercise/Conversion
Stock Options (Right to Buy)
2017-12-06−3,530→ 0 total
Exercise: $52.29From: 2015-05-07Exp: 2021-05-07→ Common Stock (3,530 underlying)
Exercise/Conversion
Stock Options (Right to Buy)
2017-12-06−3,140→ 0 total
Exercise: $70.29From: 2016-05-06Exp: 2020-05-06→ Common Stock (3,140 underlying)
Exercise/Conversion
Common Stock
2017-12-06$70.29/sh+3,140$220,711→ 66,684 total
Exercise/Conversion
Common Stock
2017-12-06$40.27/sh+7,740$311,690→ 51,444 total
Exercise/Conversion
Common Stock
2017-12-06$52.29/sh+3,530$184,584→ 63,544 total
Sale
Common Stock
2017-12-06$102.40/sh−10,227$1,047,245→ 56,457 total

Documents

1 file